colchicine has been researched along with Castleman Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ergin, M; Paydas, S | 1 |
| Arinsoy, T; Ataoglu, O; Bali, M; Derici, U; Eroglu, A; Goker, B; Sindel, S | 1 |
| Gonlusen, G; Paydas, S; Sagliker, Y | 1 |
1 review(s) available for colchicine and Castleman Disease
| Article | Year |
|---|---|
Localized Castleman's disease and nephrotic syndrome not responsive to resection plus colchicine therapy.
Topics: Adult; Amyloidosis; Castleman Disease; Colchicine; Humans; Male; Nephrotic Syndrome; Treatment Failure | 2002 |
2 other study(ies) available for colchicine and Castleman Disease
| Article | Year |
|---|---|
Colchicine therapy in amyloidosis related with plasmacytic Castleman disease presenting with nephrotic syndrome.
Topics: ADP-ribosyl Cyclase 1; Adult; Amyloidosis; Angiotensin-Converting Enzyme Inhibitors; Biopsy; Castleman Disease; Colchicine; Drug Therapy, Combination; Humans; Immunohistochemistry; Male; Membrane Glycoproteins; Nephrotic Syndrome; Serum Amyloid A Protein; Time Factors; Treatment Outcome | 2015 |
Regression of nephrotic syndrome with colchicine therapy secondary to amyloidosis with associated Castleman's disease.
Topics: Adult; Amyloidosis; Castleman Disease; Colchicine; Female; Humans; Nephrotic Syndrome | 1995 |